[Recalled] CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a contin |
|---|---|
| Brand / manufacturer | Smiths Medical ASD Inc. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2421-2024 |
| Country of notice | United States |
| Risk level | Class I |
| Hazard type | recall |
| Notice date | 27 February 2024 |
| EAN / barcode | 10610586040429 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: The CADD Solis VIP Ambulatory Infusion Pump is indicated for the following uses: " For intravenous, intraarterial, subcutaneous, intraperitoneal, perineural, surgical site, epidural space, or subarachnoid space infusion.
This Class I recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Stop using the product immediately and follow the authority's remedy (return, repair, or disposal).
Read the full official notice →
Related recalls from Smiths Medical ASD Inc.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.